Paul B. Manning - Dec 31, 2021 Form 5 Insider Report for Candel Therapeutics, Inc. (CADL)

Role
Director, 10%+ Owner
Signature
/s/ John Canepa, Attorney-in-Fact
Stock symbol
CADL
Transactions as of
Dec 31, 2021
Transactions value $
$0
Form type
5
Date filed
2/14/2022, 03:37 PM
Previous filing
Dec 6, 2021
Next filing
Feb 4, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CADL Common Stock Gift -36.8K -5.41% 642K Jul 14, 2021 By Paul B. Manning Revocable Trust F1, F2
holding CADL Common Stock 554K Dec 31, 2021 By BKB Growth Investments, LLC F3
holding CADL Common Stock 1.68M Dec 31, 2021 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares reported herein reflect the final ownership of the Reporting Person as determined in accordance with the terms of the operating agreements of PBM ADV Holdings, LLC and PBM Capital Investments II, LLC.
F2 The shares are held by The Paul B. Manning Revocable Trust dated May 10, 2000 (the "Trust"). The Reporting Person is the trustee of the Trust and has sole voting and investment power with respect to the shares held by the Trust. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
F3 The shares are held directly by BKB Growth Investments, LLC ("BKB"). The Reporting Person is a co-manager of Tiger Lily Capital, LLC, the manager of BKB, and has shared voting and investment power with respect to the shares held by BKB. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
F4 Includes shares held jointly with spouse.